Our CEO, Dr. Thomas Fessard, as panellist at Bio Integrates 2019

Leonardo Royal Hotel London Tower Bridge, London, UK | 22 May 2019

Our CEO, Dr. Thomas Fessard will be one of the panellist at Bio Integrates 2019.

Topic: What investors look for during due diligence.
What are investors’ hot buttons and red flags? How do you ensure you are properly prepared with the right data?

Time: 11:40h - 12:40h
Full Agenda: Bio Integrates 2019 Agenda

For any questions or enquiries, get in touch with our representative, Dr. Fessard.
E-mail: thomas.fessard@spirochem.com

About Bio Integrates 2019

Inspired by the ongoing success of the established Pharma Integrates event, Life Science Integrates is delighted to introduce the inaugural Bio Integrates conference. This one-day gathering of start-ups, SMEs and emerging companies will provide a platform to discuss the major challenges impacting the pharma and biotech sector.

Addressing topics such as precision medicine, cell and gene therapy, artificial intelligence, in silico and virtual trials, the focus will be on collaboration, involving stakeholders such as patient advocates, clinicians, CDMOs and CROs, charities, manufacturers, academics and medtechs.

Comprising roundtable discussions, breakout sessions and keynote presentations, delegates will benefit from updates on industry wide initiatives, alternative business models, innovative deal structures, partnering with CROs, CDMOs and the wider supply chain.

Taking place on 22 May 2019 at the Leonardo Royal Hotel (London, UK), Bio Integrates will bring together subject matter experts from the biotech and wider stakeholder community to examine and address the drivers and hurdles of today and resolve the critical business issues of tomorrow.